Impact of RFA on Esophageal Distensibility and Mucosal Impedance | MicrobiomeTrials← Back to trialsNCT07126535
Impact of RFA on Esophageal Distensibility and Mucosal Impedance
RecruitingOBSERVATIONAL
Trial Details
Start: 2025-08-19Est. Completion: 2027-07-31
Enrollment target: 10 participants Locations- Mayo Clinic, Rochester, Minnesota, United States
Other microbiome trials you might be interested in
Gastric LesionGastritisUpper Gastrointestinal Bleeding (UGIB)Gastric DysplasiaGastric UlcerGastric Neoplasms
The goal of this clinical trial is to evaluate the diagnostic accuracy of the AI-integrated Capsule Gastroscopy (ACG) sy…
Guangzhou, ChinaCompleted Feb 18, 2026
Barrett's EsophagusBarrett's Esophagus With DysplasiaEsophageal Adenocarcinoma (EAC)
The goal of this study is to learn more about genetic factors that may predict if patients with Barrett's Esophagus (BE)…
Chapel Hill, United States
Est. completion Aug 2033